Please login to the form below

Not currently logged in
Email:
Password:

Dr Ian Hudson elected vice chair of CHMP

Will serve a three-year term on EMA's scientific advisory committee

MHRA CHMP Dr Ian HudsonThe EMA's Committee for Medicinal Products for Human Use (CHMP) has elected Dr Ian Hudson to serve as its vice chair for a three-year term.

Dr Hudson has been a member of the scientific advisory committee since 2004 and is currently director of the licensing division at UK medicines regulator the MHRA.

Announcing its appointment the EMA said: “Dr Hudson brings outstanding experience and expertise from a long career in regulatory medicine and drug development, particularly in the areas of anti-infectives and oncology.”

Before joining the MHRA in 2001 Dr Hudson worked in the pharmaceutical industry for 12 years, during which time he held various clinical research and development positions at SmithKline Beecham. Prior to this he worked in clinical practice as a paediatrician.

22nd October 2012

From: Research, Sales, Regulatory

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Bedrock Group

Bedrock Healthcare Communications is a privately owned, award winning communications agency that creates and delivers highly effective, insight driven medical...

Latest intelligence

Kulveer Singh
Surviving cancer: a new era for patients
Now more than ever, a shift in perspective is needed...
Crisis? No problem!
Issues planning & management for pharma spokespeople, by Andrew Smith...
Are patient recruitment and retention rates rising or falling?
First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....

Infographics